Showing 6891-6900 of 9140 results for "".
- Powered By MRP Gets Series A Investmenthttps://practicaldermatology.com/news/powered-mrp-gets-series-investment/2467442/“Strong tailwinds behind the aesthetics market” was part of the impetus for two prominent growth equity firms to form a strategic partnership with aesthetics device company Powered By MRP, according to a press release. The Series A investment by Aries Capital Partners and Swell Collective
- Analysis: Age, Number of Mohs Surgery Stages Linked with Higher-risk Basal Cell Carcinomahttps://practicaldermatology.com/news/analysis-age-number-mohs-surgery-stages-linked-higher-risk-basal-cell-carcinoma/2467270/
- Study: 5-mm Margins Adequate for Small Melanoma in Situ Lesionshttps://practicaldermatology.com/news/study-5-mm-margins-adequate-small-mis-lesions/2467262/New research shed light on the recurrence rates of melanoma in situ (MIS) lesions removed with a 5-mm margin. "The incidence of MIS has increased significantly over the past decades, and traditional guidelines for treatment of MIS have been excision with a 5-mm clinical margin; however, c
- Event Promotes Anti-Itch Cream for Stopping Pesky Bugs From Disrupting Summer Funhttps://practicaldermatology.com/news/event-promotes-anti-itch-cream-stopping-pesky-bugs-disrupting-summer-fun/2467168/Summer is in full swing and as patients spend more time outdoors, bug bites and other skin irritants will find a way to disrupt the fun.
- Video-assisted Rhino-Septoplasty Technique Shows Validity: Studyhttps://practicaldermatology.com/news/video-assisted-rhino-septoplasty-technique-shows-validity-study/2466916/A new study suggests a video-guided rhino-septoplasty technique showed promise compared with more traditional techniques. "Conservative techniques have been developed in the field of rhinoplasty, focusing on limited tissue resection while emphasizing the reshaping of nasal structural elem
- Boehringer Ingelheim Partners with Cigna's Quallent to Expand Access to Humira Biosimilarhttps://practicaldermatology.com/news/boehringer-ingelheim-partners-cignas-quallent-expand-access-humira-biosimilar/2463055/
- Galderma Receives Filing Acceptances for Nemolizumab in Prurigo Nodularis and AD in Four Additional Countrieshttps://practicaldermatology.com/news/galderma-receives-filing-acceptances-nemolizumab-prurigo-nodularis-and-ad-four-additional-countries/2462968/
- EPI Health Issues Voluntary Recall of Several Products Following Bankruptcyhttps://practicaldermatology.com/news/epi-health-issues-voluntary-recall-several-products-following-bankruptcy/2462869/EPI Health (Novan) is initiating a voluntary recall of various within-expiry human drug products as a result of the closures and discontinuation of the post-marketing quality, regulatory and pharmacovigilance activities for these marketed products. The moves comes after EPI filed Chapter 7 bankru
- Palm Phytonutrients To Be Displayed at Expohttps://practicaldermatology.com/news/palm-phytonutrients-be-displayed-expo/2462663/As the cosmeceutical market continues to expand, so does consumer interest in learning more about the key active ingredients in cosmeceutical products and how they work, according to a press release from palm phytonutrient manufacturer PhytoGaia. PhytoGaia, a manufacturer of palm phytonut
- Analysis: Mix of Low- and Fair-quality Information for Hidradenitis Suppurativa Treatments on TikTokhttps://practicaldermatology.com/news/complementary-and-alternative-medicine-for-hidradenitis-suppurativa-discussed-on-tiktok-a-cross-sectional-analysis/2462251/Patients getting information on Hidradenitis suppurativa (HS) from TikTok were frequently exposed to low-quality information, a new study suggests. "Hidradenitis suppurativa (HS) is a painful, chronic inflammatory skin disease that negatively impacts quality of life," the